The rising prevalence in GLP-1 agonists for metabolic conditions has led to a question about application forms : skin-applied devices versus tablets . Traditionally , GLP-1 treatments were solely available in tablet form, but the introduction of transdermal delivery provides a alternative way. Patches might be advantageous for individuals facing… Read More